tiprankstipranks
Trending News
More News >
Nektar Therapeutics (NKTR)
NASDAQ:NKTR

Nektar Therapeutics (NKTR) Revenue

Compare
1,562 Followers

Nektar Therapeutics Revenue

Nektar Therapeutics had a revenue of 11.79M in the quarter ending Sep 30, 2025, with 5.50%. This bring the company's revenue in the last twelve months to 62.60M, Increased -16.46%. In the fiscal year ending Dec 31, 2024, Nektar Therapeutics had annual revenue of 98.43M with 9.22% growth.
Revenue (ttm)
62.60M
Revenue Growth
-32.79%
P/S Ratio
11.30
Revenue/Employee
$1,613,557
Employees
61
Market Cap
$1.11B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
98.43M8.30M+109.22%
Dec 31, 2023
90.12M-1.93M+97.90%
Dec 31, 2022
92.06M-9.85M+90.33%
Dec 31, 2021
101.91M-51.01M+66.64%
Dec 31, 2020
152.91M38.30M+133.41%
Dec 31, 2019
114.62M-1.08B+9.60%
Dec 31, 2018
1.19B885.61M+387.81%
Dec 31, 2017
307.71M142.28M+186.00%
Dec 31, 2016
165.44M